For older patients, those with existing sarcopenia, or those on aggressive caloric restriction, more frequent monitoring (every 34 weeks) is advisable during the dose escalation phase
A single Wegovy pen typically costs between $540 and $570 without insurance, which breaks down to approximately $400-$529 per month depending on your prescribed dose. For context, Health Canadas Drug Agency estimates annual Wegovy treatment at the list price costs approximately $5,066 per patient per year (roughly $420 per month) based on the recommended maintenance dose of 2.4 mg weekly. Current Promotional Pricing: Novo Nordisk offers a Wegovy Savings Program where self-pay patients can reduce costs to $149 per month for the 1.5 mg and 4 mg doses through April 15, 2026 (offer available for eligible patients only)
What is the difference between a 503A and a 503B compounding pharmacy
Is this safe for the Eyes
If you are evaluating Alan Meds for tirzepatide, confirm which route the plan uses and under what pharmacy licensure, because that detail defines much of what you are actually buying